Literature DB >> 27752959

Inhibition of Telomerase Activity Using an EGFP-Intron Splicing System Encoding Multiple RNAi Sequences.

O Sakiragaoglu1, A L Munn2.   

Abstract

To inhibit telomerase activity, a construct which contains artificial introns in the enhanced green fluorescent protein (EGFP) gene that encodes small hairpin RNA (shRNA) sequences that target human telomerase reverse transcriptase (hTERT) gene expression was designed and tested for its effect on lung cancer cell line. On intron splicing from the construct, intronic sequences were released and formed shRNA in the cells. After transfection of the construct, hTERT mRNA expression decreased by approximately 55 % in A549 cells. Correspondingly, in the same cell line, telomerase activity was decreased by approximately 23 %. The telomerase activity was transiently inhibited by this non-viral shRNA expression system that uses intron splicing to release artificial introns in an EGFP marker gene that contain shRNA targeting telomerase.

Entities:  

Keywords:  Cancer; EGFP; Intron splicing; Small hairpin RNA; Telomerase; hTERT

Mesh:

Substances:

Year:  2016        PMID: 27752959     DOI: 10.1007/s12033-016-9982-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  12 in total

Review 1.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

Review 2.  Gene therapy and DNA delivery systems.

Authors:  D Ibraheem; A Elaissari; H Fessi
Journal:  Int J Pharm       Date:  2013-11-25       Impact factor: 5.875

3.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

4.  Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi.

Authors:  Xing Li; Shihai Liu; Dongyang Wang; Hao Chen; Haibin Xia
Journal:  Biotechnol Lett       Date:  2011-05-05       Impact factor: 2.461

Review 5.  Current perspectives in intronic micro RNAs (miRNAs).

Authors:  Shao-Yao Ying; Shi-Lung Lin
Journal:  J Biomed Sci       Date:  2005-10-14       Impact factor: 8.410

6.  Design of expression vectors for RNA interference based on miRNAs and RNA splicing.

Authors:  Guangwei Du; Joshua Yonekubo; Yue Zeng; Mary Osisami; Michael A Frohman
Journal:  FEBS J       Date:  2006-10-31       Impact factor: 5.542

Review 7.  Senescence and immortalization: role of telomeres and telomerase.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Inhibition of telomerase activity in human cancer cells by RNA interference.

Authors:  Barbara A Kosciolek; Kriton Kalantidis; Martin Tabler; Peter T Rowley
Journal:  Mol Cancer Ther       Date:  2003-03       Impact factor: 6.261

10.  hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.

Authors:  Ying Shen; Yong-Wei Zhang; Zhi-Xiang Zhang; Ze-Hong Miao; Jian Ding
Journal:  Cancer Biol Ther       Date:  2007-11-03       Impact factor: 4.742

View more
  2 in total

Review 1.  Telomerase gene therapy: a remission toward cancer.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-04-16       Impact factor: 3.064

Review 2.  Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases.

Authors:  JinWoo Hong; Chae-Ok Yun
Journal:  Cells       Date:  2019-04-28       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.